After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. The current market capitalization of Mersana Therapeutics Inc is $53.95M. A total of 3.27 million shares were traded on the day, compared to an average of 3.51M shares.
In the most recent transaction, Mandelia Ashish sold 3,554 shares of MRSN for 0.58 per share on Jan 16 ’25. After the transaction, the VP, Chief Accounting Officer now owns 57,519 company shares. In a previous transaction on Jan 16 ’25, Protopapas Anna sold 8,637 shares at 0.58 per share. MRSN shares that Director owns now total 168,041.
Among the insiders who sold shares, Lowinger Timothy B disposed of 8,048 shares on Jan 16 ’25 at a per-share price of $0.58. This resulted in the SVP, Chief Sci.&Tech. Officer holding 257,673 shares of MRSN after the transaction. In another insider transaction, Huber Martin H. Jr. sold 4,514 shares at $0.58 per share on Jan 16 ’25. Company shares held by the President, CEO now total 122,875.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. In terms of 52-week highs and lows, MRSN has a high of $3.63 and a low of $0.26.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. MRSN’s latest balance sheet shows that the firm has $177.95M in Cash & Short Term Investments as of fiscal 2021. There were $38.18M in debt and $47.52M in liabilities at the time. Its Book Value Per Share was -$0.08, while its Total Shareholder’s Equity was $121.74M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for MRSN is Buy with a score of 4.80.
